Further Evidence of the Validity and Reliability of the Skindex-29: An Italian Study on 2,242 Dermatological Outpatients

Abeni, Damiano; Picardi, Angelo; Pasquini, Paolo; Melchi, C.F.; Chren, Mary Margaret

doi:10.1159/000051809

Cited by 106 publications

(106 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The questionnaire consists of three scales assessing burden of symptoms, social functioning and emotional state. The Skindex-29 has repeatedly been shown to be a valid and reliable tool for measuring health-related quality of life in dermatological patients [17,18,19]. We used the validated Italian version [19].…”

Section: Methodsmentioning

confidence: 99%

Psychosomatic Assessment of Skin Diseases in Clinical Practice

Picardi

Pasquini

Abeni

et al. 2005

Psychother Psychosom

Self Cite

View full text Add to dashboard Cite

Background: Psychiatric disorders are frequent in dermatology patients, and many studies pointed out complex, mutual relationships between psyche and skin. Our aim was to provide a systematic psychosocial evaluation of a large and heterogeneous population of patients with skin diseases, including assessments of quality of life, psychiatric status according to the DSM-IV and psychological conditions with psychosomatic relevance according to established criteria (Diagnostic Criteria for Psychosomatic Research, DCPR). Methods: We studied 545 dermatological inpatients aged 18–65 years, free from dementia and cognitive impairment. They completed the Skindex-29 and the 12-item General Health Questionnaire (GHQ-12) and were administered the SCID-I and the Structured Interview for Psychological Conditions of Psychosomatic Relevance by a trained mental health professional blinded to questionnaire scores. Results: Overall, 38% of patients received a DSM-IV diagnosis. The most common diagnoses were mood (20%) and anxiety disorders (16%); 48% of patients also received a DCPR diagnosis. The most common were demoralisation, irritable mood, type A behaviour and various forms of abnormal illness behaviour. Adjusting for gender, age, and education, the presence of DSM-IV or DCPR diagnoses was significantly associated with high scores on the GHQ-12 and on the Functioning and Emotions scales of the Skindex-29. Also, DCPR diagnoses were significantly associated with high scores on the Symptoms scale of the Skindex-29. Conclusions: These findings highlight the high frequency of psychosocial problems in patients with skin disease and suggest that the joint use of DSM-IV and DCPR criteria may help identify those patients in whom psychiatric issues are worthy of increased clinical attention.

show abstract

Section: Methodsmentioning

confidence: 99%

Psychosomatic Assessment of Skin Diseases in Clinical Practice

Picardi

Pasquini

Abeni

et al. 2005

Psychother Psychosom

Self Cite

View full text Add to dashboard Cite

show abstract

“…Cabe anotar que los resultados obtenidos en este estudio en lo referente a la fiabilidad y a la validez de constructo en grupos extremos coinciden con los reportados tanto en la versión original en inglés del Skindex-29 como en sus versiones española e italiana (2,14,16), pero los nuestros no se pueden comparar directamente con los de estudios publicados acerca de este tipo de evaluación rigurosa con otros instrumentos que evalúan la CV dermatológica tales como el DLQI. Se hace, por tanto, necesario evaluar estas mismas propiedades psicométricas en las demás versiones del Skindex-29 que se han traducido y adaptado a otros idiomas y países.…”

Section: Discussionunclassified

“…Los instrumentos genéricos más usados en estos pacientes dermatológicos son el SF-36 (Short-Form-36) y el WHOQOL (Índice de calidad de vida de la Organización Mundial de la Salud). No obstante, tanto estos como muchos otros instrumentos genéricos que se utilizan en pacientes dermatológicos carecen de especificidad para detectar el impacto que tienen las enfermedades de la piel en los individuos (1,2). Es así como se han diseñado instrumentos específicos tales como el DLQI (Dermatology Life Quality Index) y el Skindex (2-4).…”

Section: Introductionunclassified

Fiabilidad y validez de constructo de la versión colombiana del instrumento de calidad de vida Skindex-29© en Medellín, Colombia

Sanclemente-Mesa

García

Aguirre-Acevedo

et al. 2017

iatreia

View full text Add to dashboard Cite

Introducción: la adaptación cultural de los instrumentos de calidad de vida y su evaluación psicométrica se deben hacer de forma rigurosa y estandarizada.Objetivo: evaluar la fiabilidad y la validez de constructo de la versión colombiana del instrumento Skindex-29©.Métodos: se incluyeron pacientes con enfermedades cutáneas inflamatorias o generalizadas; con enfermedades no inflamatorias o localizadas, e individuos sanos y se determinó la fiabilidad intraobservador e interobservador.Resultados: se encuestaron 265 individuos. El coeficiente alfa de Cronbach fue de 0,957 para el instrumento total. Los coeficientes de correlación intraclase de la consistencia intraobservador e interobservador fueron superiores al 0,9. Los pacientes con enfermedades dermatológicas generalizadas y con dermatosis inflamatorias tuvieron puntuaciones más altas que las de aquellos con lesiones cutáneas no inflamatorias o aisladas.Conclusiones: los resultados corroboran la validez de constructo del instrumento estudiado. En el futuro es necesario evaluar otras propiedades psicométricas del mismo tales como su validez de contenido y de criterio y su sensibilidad al cambio. Objective: This study assessed the reliability and construct validity of the Colombian version of the Skindex-29 instrument.Methods: Patients with inflammatory or generalized skin diseases and with non-inflammatory or localized diseases, and healthy individuals were included. We determined the intra-and inter-observer reliability.Results: We surveyed 265 individuals. Cronbach's alpha was 0.957 for the total instrument. The intraclass correlation coefficients for intra-observer and inter-observer consistency were higher than 0.9. Patients with generalized or inflammatory diseases had higher scores than those with non-inflammatory or isolated lesions. Conclusions:The results support the construct validity of the studied instrument. In the future, it is necessary to evaluate other psychometric properties such as its content and criteria validity, and its sensitivity to change.

show abstract

“…The DLQI has shown to have good reliability and validity when used in a dermatological setting (12)(13). This is a reliable and valid instrument that has been specifically designed for measuring QoL in dermatological patients (14)(15).…”

Section: Methodsmentioning

confidence: 99%

Continuous Treatment of Plaque-Type Psoriasis with Etanercept: An Observational Long-Term Experience

Esposito

Giunta

Mazzotta

et al. 2010

Int J Immunopathol Pharmacol

View full text Add to dashboard Cite

To assess the long-term efficacy and safety profile and the patient-reported outcomes (PRO) in patients with moderate-to-severe plaque-type psoriasis receiving continuous etanercept treatment. An open-label study was conducted to evaluate etanercept as long-term treatment for moderate-to-severe plaque psoriasis. Continuous therapy was administered at a dose of 50 mg subcutaneously twice weekly for 12 weeks followed by a continuous treatment with 50 mg subcutaneously once weekly or 25 mg twice weekly throughout a 96-week study. The primary measure of efficacy was the proportion of patients with PASI 75 at week 24, 48 and 96. Patient-reported outcomes (PRO) were also assessed during the study, at week 24, 48 and 96, including the Dermatology Life Quality Index (DLQI) and the Psoriasis Disability Index (PDI). At baseline, mean PASI score, DLQI and PDI for patients eligible to initiate treatment with etanercept showed significant disease severity, quality-of-Iife impairment and psoriasis-related disability. At week 96, patients showed statistically significant and meaningful improvements. The continuous etanercept regimen provided a consistent improvement in both clinical disease parameters and PRO measures.

show abstract

Further Evidence of the Validity and Reliability of the Skindex-29: An Italian Study on 2,242 Dermatological Outpatients

Cited by 106 publications

References 17 publications

Psychosomatic Assessment of Skin Diseases in Clinical Practice

Psychosomatic Assessment of Skin Diseases in Clinical Practice

Fiabilidad y validez de constructo de la versión colombiana del instrumento de calidad de vida Skindex-29© en Medellín, Colombia

Continuous Treatment of Plaque-Type Psoriasis with Etanercept: An Observational Long-Term Experience

Contact Info

Product

Resources

About